BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32866294)

  • 21. p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1.
    Okubo T; Saito T; Mitomi H; Takagi T; Torigoe T; Suehara Y; Kaneko K; Yao T
    Virchows Arch; 2013 Jul; 463(1):67-77. PubMed ID: 23748877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
    Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
    Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological Diagnosis of Giant Cell Tumor of Bone.
    Miskad UA; Syamsul F; Dahlan H; Sungowati NK; Achmad D; Johan MP
    Asian Pac J Cancer Prev; 2023 May; 24(5):1737-1741. PubMed ID: 37247296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases.
    Yang L; Zhang H; Zhang X; Tang Y; Wu Z; Wang Y; Huang H; Fu X; Liu J; Hogendoorn PCW; Cheng H
    Ann Diagn Pathol; 2022 Apr; 57():151882. PubMed ID: 34995868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symplastic/pseudoanaplastic giant cell tumor of the bone.
    Sarungbam J; Agaram N; Hwang S; Lu C; Wang L; Healey J; Hameed M
    Skeletal Radiol; 2016 Jul; 45(7):929-35. PubMed ID: 27020452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics.
    Guimarães LM; Baumhoer D; Andrei V; Friedel D; Koelsche C; Gomez RS; von Deimling A; Gomes CC
    J Pathol Clin Res; 2023 Nov; 9(6):464-474. PubMed ID: 37555357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone.
    Alberghini M; Kliskey K; Krenacs T; Picci P; Kindblom L; Forsyth R; Athanasou NA
    Virchows Arch; 2010 Jan; 456(1):97-103. PubMed ID: 20012988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells.
    Fellenberg J; Sähr H; Mancarella D; Plass C; Lindroth AM; Westhauser F; Lehner B; Ewerbeck V
    Cancer Lett; 2019 Apr; 448():61-69. PubMed ID: 30742944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
    Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The two faces of giant cell tumor of bone.
    Scotto di Carlo F; Whyte MP; Gianfrancesco F
    Cancer Lett; 2020 Oct; 489():1-8. PubMed ID: 32502498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation.
    Ishihara S; Yamamoto H; Iwasaki T; Toda Y; Yamamoto T; Yoshimoto M; Ito Y; Susuki Y; Kawaguchi K; Kinoshita I; Yamada Y; Kohashi K; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Kakuda Y; Nakashima Y; Oda Y
    Mod Pathol; 2022 May; 35(5):640-648. PubMed ID: 34785767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone.
    Lutsik P; Baude A; Mancarella D; Öz S; Kühn A; Toth R; Hey J; Toprak UH; Lim J; Nguyen VH; Jiang C; Mayakonda A; Hartmann M; Rosemann F; Breuer K; Vonficht D; Grünschläger F; Lee S; Schuhmacher MK; Kusevic D; Jauch A; Weichenhan D; Zustin J; Schlesner M; Haas S; Park JH; Park YJ; Oppermann U; Jeltsch A; Haller F; Fellenberg J; Lindroth AM; Plass C
    Nat Commun; 2020 Oct; 11(1):5414. PubMed ID: 33110075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of H3.3 G34W mutant-specific antibody in giant cell tumors of bone and its diagnostic value].
    Wang X; Wu N; Zhang RS; Wei X; Ji RH; Ma HH; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):116-121. PubMed ID: 32074722
    [No Abstract]   [Full Text] [Related]  

  • 34. Genome-Wide Transcriptome Profiling of the Neoplastic Giant Cell Tumor of Bone Stromal Cells by RNA Sequencing.
    Lau CP; Kwok JS; Tsui JC; Huang L; Yang KY; Tsui SK; Kumta SM
    J Cell Biochem; 2017 Jun; 118(6):1349-1360. PubMed ID: 27862217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
    Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
    Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability and Role of Mutation-specific H3F3A (Histone 3-3) G34W Immunohistochemistry to Differentiate Giant Cell Tumor of Bone From its Clinicoradiologic and Histologic Mimics: An Institutional Study.
    Pasricha S; Pruthi M; Jajodia A; Kumar A; Gupta G; Sharma A; Tiwari A; Rohela H; Durga G; Kamboj M; Koyyala VPB; Mehta A
    Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):36-41. PubMed ID: 34347625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological and clinical characteristics of malignant giant cell tumor of bone.
    Gong L; Liu W; Sun X; Sajdik C; Tian X; Niu X; Huang X
    Virchows Arch; 2012 Mar; 460(3):327-34. PubMed ID: 22350004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of giant cell tumour of bone cells for Noonan syndrome/cherubism-related mutations.
    Moskovszky L; Idowu B; Taylor R; Mertens F; Athanasou N; Flanagan A
    J Oral Pathol Med; 2013 Jan; 42(1):95-8. PubMed ID: 22725657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of H3.3 G34W in 100 giant cell tumors of bone and its diagnostic mimics, including its value in resolving uncommon diagnostic scenarios: A single institutional study at a tertiary cancer referral center, India.
    Rekhi B; Dave V; Butle A; Dharavath B; Khetale S; Redhu AK; Singh R; Dutt A
    Indian J Pathol Microbiol; 2024 Feb; ():. PubMed ID: 38391356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical genomic profiling of malignant giant cell tumor of bone: A retrospective analysis using a real‑world database.
    Tsuda Y; Okajima K; Ishibashi Y; Zhang L; Hirai T; Kage H; Shinozaki-Ushiku A; Oda K; Tanaka S; Kobayashi H
    Med Int (Lond); 2024; 4(2):17. PubMed ID: 38476985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.